Literature DB >> 11955809

Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design.

Carla Sánchez-Lafuente1, Sandra Furlanetto, Mercedes Fernández-Arévalo, Josefa Alvarez-Fuentes, Antonio M Rabasco, M Teresa Faucci, Sergio Pinzauti, Paola Mura.   

Abstract

Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955809     DOI: 10.1016/s0378-5173(02)00028-5

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  The science of USP 1 and 2 dissolution: present challenges and future relevance.

Authors:  Vivian Gray; Gregg Kelly; Min Xia; Chris Butler; Saji Thomas; Stephen Mayock
Journal:  Pharm Res       Date:  2009-01-23       Impact factor: 4.200

2.  Effect of Kollidon® SR on the release of Albuterol Sulphate from matrix tablets.

Authors:  Walid Sakr; Fars Alanazi; Adel Sakr
Journal:  Saudi Pharm J       Date:  2010-11-04       Impact factor: 4.330

3.  Synthesis of PCEC Copolymers with Controlled Molecular Weight Using Full Factorial Methodology.

Authors:  Leila Barghi; Davoud Asgari; Jaleh Barar; Hadi Valizadeh
Journal:  Adv Pharm Bull       Date:  2015-03-05

4.  Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form.

Authors:  A Palamakula; Mohammad T H Nutan; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

5.  Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.

Authors:  Atul Kuksal; Ashok K Tiwary; Narendra K Jain; Subheet Jain
Journal:  AAPS PharmSciTech       Date:  2006-01-03       Impact factor: 3.246

6.  Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design.

Authors:  Gurinder Singh; Roopa S Pai; V Kusum Devi
Journal:  J Adv Pharm Technol Res       Date:  2012-01

7.  Systematic development of self-emulsifying drug delivery systems of atorvastatin with improved bioavailability potential.

Authors:  Fariba Khan; Md Saiful Islam; Monzurul Amin Roni; Reza-Ul Jalil
Journal:  Sci Pharm       Date:  2012-07-22

8.  Optimization of Paclitaxel Containing pH-Sensitive Liposomes By 3 Factor, 3 Level Box-Behnken Design.

Authors:  Smita Rane; Bala Prabhakar
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.